MEDICO REMEDIES share price has plunged 6% and is presently trading at Rs 57.6.
Meanwhile, the BSE HEALTHCARE index is at 43,672.0 (down 1.2%).
Among the top losers in the BSE HEALTHCARE index today are GSK Pharma (down 4.3%) and J.B.Chemicals (down 4.2%).
KIMS (up 2.3%) and Cipla (up 1.3%) are among the top gainers today.
Over the last one year, MEDICO REMEDIES has moved down from Rs 75.0 to Rs 57.6, registering a loss of Rs 17.4 (down 23.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,271.8 to 43,672.0, registering a gain of 60.1% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 235.1%), SUVEN PHARMACEUTICALS (up 127.4%) and Glenmark Pharma (up 124.0%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 78,480.3 (down 1.7%).
The top losers among the BSE Sensex today are Bajaj Finserv (down 3.9%) and MUNDRA PORT & SEZ (down 3.7%). The most traded stocks in the BSE Sensex are ICICI Bank and Tata Steel.
In the meantime, NSE Nifty is at 23,897.6 (down 1.7%). Hero Motocorp and Bajaj Auto are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,874.9 to 78,480.3, registering a gain of 14,605.4 points (up 22.9%).
MEDICO REMEDIES net profit grew 19.5% YoY to Rs 16 million for the quarter ended June 2024, compared to a profit of Rs 13 million a year ago. Net sales declined 2.1% to Rs 308 million during the period as against Rs 315 million in April-June 2023.
For the year ended March 2024, MEDICO REMEDIES reported 14.5% increase in net profit to Rs 83 million compared to net profit of Rs 72 million during FY23. Revenue of the company grew 3.2% to Rs 1,449 million during FY24.
The current Price to earnings ratio of MEDICO REMEDIES , based on rolling 12 month earnings, stands at 55.9.
Equitymaster requests your view! Post a comment on "MEDICO REMEDIES Plunges 6%; BSE HEALTHCARE Index Down 1.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!